• Publications
  • Influence
Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments.
OBJECTIVE Nonpharmacological treatments are available for attention deficit hyperactivity disorder (ADHD), although their efficacy remains uncertain. The authors undertook meta-analyses of theExpand
  • 795
  • 45
  • PDF
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
Quality of life (QoL) describes an individual’s subjective perception of their position in life as evidenced by their physical, psychological, and social functioning. QoL has become an increasinglyExpand
  • 342
  • 40
European clinical guidelines for hyperkinetic disorder – first upgrade
AbstractBackgroundThe validity of clinical guidelines changes over time, because new evidencebased knowledge and experience develop.ObjectiveHence, the European clinical guidelines on hyperkineticExpand
  • 609
  • 34
  • PDF
European guidelines on managing adverse effects of medication for ADHD
The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemporary-standard information about medications first licensed several decades ago, and signals ofExpand
  • 308
  • 15
  • PDF
Practitioner review: Quality of life in child mental health--conceptual challenges and practical choices.
The terms ‘quality of life’ (QoL) and ‘health related quality of life’ (HRQoL) are fraught with preconceptions, misconceptions and, frequently, confusion: How are these terms best defined? What areExpand
  • 101
  • 13
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline.
A systematic review of published and unpublished data on the use of long-acting medications in ADHD and hyperkinetic disorder is reported, giving effect sizes and numbers-to-treat forExpand
  • 218
  • 12
Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains.
OBJECTIVE Behavioral interventions are recommended as attention-deficit/hyperactivity disorder (ADHD) treatments. However, a recent meta-analysis found no effects on core ADHD symptoms when ratersExpand
  • 212
  • 12
Hyperactivity and conduct problems as risk factors for adolescent development.
OBJECTIVE To clarify the developmental risk associated with hyperactive behavior, especially the relationship between hyperactive and conduct problems, in a longitudinal epidemiological design. Expand
  • 433
  • 10
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.
OBJECTIVE Attention-deficit/hyperactivity disorder (ADHD) is typically treated over extended periods; however, few placebo-controlled, long-term studies of efficacy have been reported. METHOD In aExpand
  • 134
  • 10
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
BACKGROUND Medication is an important element of therapeutic strategies for ADHD. While medications for ADHD are generally well-tolerated, there are common, although less severe, as well as rare butExpand
  • 213
  • 9
  • PDF